TKNO(Alpha Teknova, Inc.) · 财务报表

TKNO(Alpha Teknova, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$36.89M$41.42M$36.68M$37.74M$40.52M
毛利润$17.62M$17.48M$10.30M$7.23M$13.44M
营业利润−$12.01M−$49.66M−$35.56M−$26.15M−$16.98M
净利润−$9.80M−$47.47M−$36.78M−$26.75M−$17.26M
经营现金流−$9.07M−$27.40M−$18.81M−$12.39M−$8.65M
自由现金流−$28.95M−$55.55M−$26.75M−$13.52M−$9.79M
摊薄每股收益$-0.61$-1.69$-1.16$-0.57$-0.32

Alpha Teknova, Inc. TKNO